AtheroMed, Inc. Announces Launch Of EASE Clinical Trial To Evaluate Peripheral Arterial Disease Treatment

Links shared publicly online about this topic.

886
total visits

AtheroMed, Inc. Announces Launch Of EASE Clinical Trial To Evaluate Peripheral Arterial Disease Treatment

AtheroMed, Inc. announced the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatme

View full resource at medicalnewstoday.com

Tags: Disease and Condition, Clinical Trial, disease, Safety

Most Recently Shared on September 9, 2010 at 3:00 pm By:

MNT Clinical Trials

AtheroMed, Inc. Announces Launch Of EASE Clinical Trial To Evaluate Peripheral Arterial Disease Treatment http://mnt.to/3JtB #clinicaltrials

2 years ago...

Retweet

Favorite

Also Shared By:

MNT Vascular

AtheroMed initiates enrollment in Phoenix Atherectomy catheter trial for PAD

news-medical.net — “AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy" catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.” View full resource at news-medical.net